SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-23-000050
Filing Date
2023-08-09
Accepted
2023-08-09 16:03:44
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20230630.htm   iXBRL 10-Q 1144287
2 EX-10.1 a101_ligand-directorcompen.htm EX-10.1 29569
3 EX-31.1 lgnd_63023exhibit311.htm EX-31.1 15159
4 EX-31.2 lgnd_63023exhibit312.htm EX-31.2 15429
5 EX-32.1 lgnd_63023exhibit321.htm EX-32.1 11158
11 lgnd-20230630_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-23-000050.txt   7089631

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20230630.xsd EX-101.SCH 44160
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20230630_cal.xml EX-101.CAL 87777
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20230630_def.xml EX-101.DEF 240254
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20230630_lab.xml EX-101.LAB 710907
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20230630_pre.xml EX-101.PRE 425201
57 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20230630_htm.xml XML 1019102
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 231155026
SIC: 2834 Pharmaceutical Preparations